Clinical Trial Search

Primary: Deterioration by 6 Months - Older Cohort — 10; 1; 7; 1 Participants — p=0.004

Primary: Exotropia Control Score at Distance, Continuous Score — 3.6; 3.3 units on a scale

Primary: Mean Distance Exotropia Control Score — 2.0; 2.8 points on control score scale — p=0.01

Primary: Mean Distance Control at 12-Months (On-Treatment Visit) — 1.8; 2.8 points

Primary: Number of Participants With Suboptimal Surgical Outcome as Assessed by Motor Alignment and Stereoacuity at Near by 3 Years — 43; 33 Participants — p=0.24

Primary: Quality of Life (0-100 Point) — 76.8; 59.8 units on a scale

Primary: Difference in the Absolute Walking Distance (AWD) at 3 Months Between the Two Treatment Groups — 220.12; 242.97; 327.74; 370.38 Meters — p=0.28

Primary: Total Local Anesthetic Utilized in First 24 Hours — 126; 123 mg — p=0.74

Primary: Residual Urine Measured by Ultra Sound — 11; 6 ml — p=0.56

Primary: Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia. — 11.3; 11.1; 10.3 mg bupivacaine per hour — p=>0.05

Primary: the Ratio of the Enteral Nutrition — 0.98; 0.73 ratio

Primary: Number of Participants With a Change in Mean Distance Control Scores at 3 Months — 1; 0; 4; 4 Participants

Primary: Ocular Alignment at Distant Fixation — 5.8; 1.1 prism diopter

Primary: Acceptability of Test Hydrophilic Intermittent Catheter — 45; 4; 4; 2 Participants

Primary: IPC(on) Peak Velocity Change From Baseline — 6.2 cm/s